Agomab与SpyGlass携手登陆纳斯达克,IPO总额达3.5亿美元
Agomab, SpyGlass head to Nasdaq with IPOs totaling $350M
生物技术与制药领域的最新动态
Agomab, SpyGlass head to Nasdaq with IPOs totaling $350M
NICE greenlights Abbott's cardiac sensor implant for NHS
Roivant spinout Priovant touts Phase 2 brepocitinib data in cutaneous sarcoidosis
Linscomb Wealth Inc. Invests $2.94 Million in Agilent Technologies, Inc. $A - MarketBeat
Illumina bets on healthcare after Trump administration's NIH funding disruptions
Illumina bets on healthcare customers after NIH funding disruptions - Endpoints News
PBSA Market Is Booming Worldwide With Agilent Technologies • Bio-Rad Laboratories • PerkinElmer • Illumina - openPR.com
Agilent Technologies (A) Valuation Check After New Automation And AI Lab Tools Showcase - simplywall.st
Illumina Q4 Earnings Call Highlights - Yahoo Finance
Agomab, SpyGlass bank a combined $350M in biotech IPOs
FDA chief Makary takes aim at Hims' compounded Wegovy pill plans
Illumina: Q4 Earnings Snapshot - kens5.com
Illumina shares tumble as flat revenue disappoints investors By Investing.com - Investing.com
Illumina Inc. Q4 Profit Advances - Nasdaq
Earnings roundup: AbbVie angst, a bifurcated vaccine market and Bristol Myers’ waiting game
Novo's threat to sue Hims over Wegovy pill faces legal hurdle
Illumina (NASDAQ:ILMN) Reports Bullish Q4 CY2025 - TradingView
Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2025 - PR Newswire
White House plans to launch TrumpRx Thursday
Astellas tops expectations as Vyloy sales surge outshines trial setback